Two of the members of the CIRM governing board, Chair Jon Thomas and Vice Chair Art Torres, during an earlier meeting.(Photo: CIRM)Directors of the $12 billion California stem cell agency have moved to weaken conflict of interest provisions affecting its governing board — eliminating “leave-the-room” requirements that are used by most private nonprofits to assure the integrity of their operations.
Close up of laboratory microscope with DNA gel background image. (Photo: 18percentgrey, via Shutterstock)Directors of the California stem cell agency last week handed out $2 million a minute to nearly 20 organizations during an online meeting that spread the largess from Sacramento in the north to San Diego in the south.
Stem cell researcher and professor Larry Goldstein. (Photo: Screen capture, UCTV).Larry Goldstein, a well-known stem cell researcher at the University of California, San Diego who has received nearly $22 million in awards from the California stem cell agency, today was named to its governing board. It was the first time in the history of the 16-year-old agency that a scientist who has received agency awards has been appointed to the board.
A scientist at work in a biological lab. (Photo: anyaivanova)California voters have apparently approved spending $5.5 billion more on stem cell research over the next 10 to 15 years and significantly broadening the scope of its state stem cell agency, according to unofficial figures this morning.
Personnel at UCSF's facility in Fresno, which may benefit if Proposition 14 is approved. (Photo: UCSF)Proposition 14, the fall ballot measure to save California’s stem cell agency from financial extinction, contains much, much more than the $5.5 billion that it is seeking from the state’s voters. Added to the agency’s charter would be research involving mental health, “therapy delivery,” personalized medicine and “aging as a pathology.“ That is not to mention a greater emphasis on supporting “vital research opportunities” that are not stem cell-related.
Rudy Giuliani, left, and Robert Hariri. (Photo: Hariri Twitter page.)California’s stem cell agency last week awarded $750,000 to a New Jersey firm to help finance a clinical trial for the firm’s proposed Covid-19 treatment — a therapy that has been hailed by President Trump’s personal attorney as having “real potential.” The firm is Celularity, Inc. Its president and co-founder is Robert Hariri, who describes himself as a longtime friend of Rudy Giuliani.
Eagle Lake in the Sierra Nevada's Desolation Wilderness west of Lake Tahoe. (Photo: William Cushman, via Shutterstock) OPINION: While it is no surprise where the Trump administration’s priorities lie when it comes to our public lands during this shutdown, the brazenness of their disregard for our protected public lands in favor of special interests should make it crystal clear what matters to them most.